News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment interruptions news

Show

From To
Treatment interruptions
Study finds smaller CD4 response to successful antiretroviral therapy following treatment interruptions

HIV-positive people who stop taking antiretroviral therapy and then start again are likely to see smaller CD4 cell count increases than they did when they

Published
29 December 2008
By
Kelly Safreed-Harmon
Treatment interruptions
The return of treatment interruptions?

By Edwin J Bernard. Reporting by Gus Cairns.

Published
01 December 2008
From
HIV treatment update
Changing treatment
If you can't switch, better to stay on failing treatment than stop it, studies show

Patients on failing drug regimens maintain stable CD4 counts with detectable viral load levels up to 10,000 copies/ml, as long as they remain on HIV

Published
14 November 2008
By
Gus Cairns
Adherence
Treatment breaks set for a come-back?

Two and half years after a major study of HIV treatment interruption was halted because of a higher risk of death in people who stopped

Published
12 November 2008
By
Gus Cairns
Side-effects
Continued antiretroviral therapy reduces bone mineral density in SMART study

A sub-study of the SMART trial has found greater losses of bone mineral density in people who stayed on continuous antiretroviral therapy, compared to those

Published
27 October 2008
By
Derek Thaczuk
HIV treatment
BHIVA: Many patients and clinicians still need educating about the benefits of treatment

Both HIV-positive individuals and their clinicians require further education around the benefits of earlier initiation of therapy, and better understanding of the risks of treatment

Published
08 May 2008
By
Edwin J. Bernard
Resistance
Planned interruption of highly active antiretroviral therapy does not select drug resistance mutations in HIV-1-infected children

Stopping highly active antiretroviral therapy (HAART) containing two non-nucleoside reverse transcriptase inhibitors (NNRTI) for 9 or 14 days in HIV-1-infected children with viral suppression did

Published
07 May 2008
By
Tom Egwang
Treatment interruptions
SMART study reaffirms that HIV replication is harmful, even at CD4 counts above 350

Uncontrolled HIV replication is associated with a higher risk of serious illness and death even when the CD4 cell count is above the currently recommended

Published
14 April 2008
By
Tom Egwang
Treatment interruptions
Benefit of starting HIV treatment early outweighs the risk of toxicities, SMART study shows

Starting antiretroviral therapy at a CD4 cell count above 350 - the current threshold for starting treatment - reduced the risk of serious illness and

Published
14 April 2008
By
Tom Egwang
Treatment interruptions
CROI: Biomarker changes may help explain detrimental effects of treatment interruption

Several biomarkers associated with inflammation, blood coagulation, or endothelial dysfunction are significantly elevated during treatment interruption and may partially explain the increased risk of cardiovascular

Published
07 February 2008
By
Liz Highleyman
← Prev1...34567...10Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.